MetaCap

Perrigo Company plc Company Profile

NYSE: PRGOHealth CareBiotechnology: Pharmaceutical PreparationsUSD

14.55+0.55 (+3.93%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

Pre-market: 14.55 0.00%

Perrigo at a glance

Perrigo Company plc (NYSE: PRGO) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Dublin. Perrigo is led by Mr. Albert Ange Manzone and employs about 8,100 people. At a market capitalization of $2.01 billion, it is considered a mid-cap company.

Its SEC Central Index Key (CIK) is 0001585364, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Perrigo do?

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Business description based on the company's public filings.

Company information

Legal name
Perrigo Company plc
Ticker
NYSE: PRGO
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Albert Ange Manzone
Employees
8,100
Headquarters
The Sharp Building, Dublin, United States
Phone
353 1 709 4000
SEC CIK
0001585364

Companies similar to Perrigo

PRGO peer companies
CompanyPrice% ChgMarket capCompare
SDGRSchrodinger Inc.27.29-5.57%$2.04Bvs PRGO
LKFTLakefront Biotherapeutics ADR30.00+2.32%$1.96Bvs PRGO
VRDNViridian Therapeutics Inc.18.28+0.33%$2.07Bvs PRGO
MLYSMineralys Therapeutics Inc.22.09+0.64%$1.95Bvs PRGO
ZYMEZymeworks Inc.26.53+3.43%$1.90Bvs PRGO
GPCRStructure Therapeutics Inc. ADR26.68-2.88%$1.90Bvs PRGO
AGIOAgios Pharmaceuticals Inc.31.79+0.22%$1.90Bvs PRGO
PVLAPalvella Therapeutics Inc.130.59+2.02%$1.88Bvs PRGO

Related